tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market

Coherus Biosciences (CHRS) Income Statement

Compare
1,658 Followers

Coherus Biosciences Income Statement

Last quarter (Q4 2025), Coherus Biosciences's total revenue was $12.75M, a decrease of -76.46% from the same quarter last year. In Q4, Coherus Biosciences's net income was $-375.96M. See Coherus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 42.17M$ 266.96M$ 257.24M$ 211.04M$ 326.55M
Gross Profit
$ 24.43M$ 149.41M$ 98.25M$ 140.96M$ 268.96M
Operating Expenses
$ 203.97M$ 261.07M$ 301.45M$ 397.84M$ 532.82M
Depreciation and Amortization
$ 3.92M$ 5.28M$ 3.79M$ 3.70M$ 3.45M
EBITDA
$ -175.61M$ 60.94M$ -193.94M$ -255.58M$ -260.69M
Operating Income
$ -179.53M$ -111.67M$ -203.20M$ -256.88M$ -263.86M
Other Income/Expenses
$ -3.59M$ 140.17M$ -35.07M$ -34.87M$ -23.24M
Pretax Income
$ -183.12M$ 28.51M$ -238.27M$ -291.75M$ -287.10M
Net Income
$ -170.29M$ 28.51M$ -237.89M$ -291.75M$ -287.10M
Per Share Metrics
Basic EPS
$ -1.45$ 0.25$ -2.53$ -3.76$ -3.81
Diluted EPS
$ -1.45$ 0.25$ -2.53$ -3.76$ -3.81
Weighted Average Shares Outstanding
120.37M 114.55M 94.16M 77.63M 75.45M
Weighted Average Shares Outstanding (Diluted)
120.37M 114.83M 94.16M 77.63M 75.45M
Currency in USD

Coherus Biosciences Earnings and Revenue History